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Abstract 
 
Aqueous, ethanolic and hexane extracts of the leaves of Nauclea latifolia (Rubiaceae) were assessed for 
their fasting blood glucose lowering effect in normoglycaemic and streptozotocin – diabetic rats. Wistar strain 
albino rats were given different doses of the extracts after 18 hrs fast and their blood glucose measured at 0,1,2,4 and 
6 hours after treatment. The aqueous and ethanolic extracts significantly lowered the fasting blood glucose levels of 
the STZ–diabetic rats in a dose–dependent manner. The highest dose administered (400mg/kg) lowered the fasting 
blood glucose of the diabetic rats by 31.7% (aqueous) and 36.1% (ethanolic) extracts. The aqueous extract did not 
significantly lower the glucose levels of normoglycaemic rats (maximum 6.6%), nor was any significant decrease 
seen in the rats administered with the hexane (maximum of 4.0% for normoglycaemic and 2.4% for diabetics) 
extract. The hypoglycaemic and antihyperglycaemic potentials of the aqueous and ethanolic extracts were 
comparable to that of glibenclamide (1mg/kg).These results further support the traditional use of the plant in the 
treatment of diabetes mellitus. 
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Introduction 
 
Diabetes mellitus (DM) is a common metabolic disorder affecting people in both developed and developing 
countries. Diabetics can be divided into two main groups based on their requirements for insulin:  insulin dependent 
diabetes mellitus (Type 1) and non – insulin dependent diabetes mellitus (Type 2).  The disease is characterized by 
chronic hyperglycaemia, which if not effectively controlled can cause blindness, kidney failure or nerve damage. 
Type 2 diabetes is the most prevalent, and accounts for approximately 90% of cases of diabetes mellitus worldwide 
(WHO 2002), and is characterized by a combination of defects in insulin secretion and insulin sensitivity. 
Glycaemic control is one of the targets for managing DM. Studies have confirmed that for the type 2 diabetes, 
effective control of blood glucose substantially decrease the risk of developing complications of diabetes (Ohkubo et 
al., 1995; UKPDS, 1997). 
The many side effects of insulin therapy and oral hypoglycaemic agents (Holman and Turner, 1991; Rao et 
al., 1997) necessitated the search for more effective and safer antidiabetic drugs. Scientific search for 
hypoglycaemic agents from medicinal plants as recommended by the World Health Organisation (The WHO expert 
committee, 1980) has become even more important. In the last few decades over 500 herbal medicines have been 
reported to possess antidiabetic property (Handa et al., 1989; Ivorra et al., 1989; Jia et al., 2003). 
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Nauclea latifolia Smith ( Rubiaceae ) is a straggling shrub or small tree native to tropical Africa and Asia. It is 
reported to be used in the treatment of malaria (kokwaro, 1976; Akubue and Mittal, 1982; Boye, 1990), GIT 
disorders (Madubunyi, 1995), sleeping sickness (Kerharo, 1974), prolong menstrual flow (Elujoba, 1995) and 
hypertension (Akubue and Mittal, 1982). Different parts of N. latifolia are commonly prescribed traditionally as a 
remedy for diabetes mellitus. The veracity of these claims has not been established scientifically. Recently, we 
reported the antidiabetic property of the aqueous extract of the leaves of the plant (Gidado et al., 2005). In this study, 
we compare the fasting blood glucose lowering effect of different doses of aqueous, ethanolic and hexane extracts of 
the leaves of N. latifolia on both normal and streptozotocin-induced diabetic rats. 
 
 
Materials and Methods  
Plant material 
 
Fresh leaves of N. latifolia were collected from  Ahmadu Bello University main campus. It was identified 
and authenticated at the herbarium unit of Biological Sciences, Department, A.B.U. Zaria. It was identical with the 
voucher specimen (No. 1268) previously deposited at the herbarium. The leaves were dried under the shade and 
ground into powder with pestle and mortar. 
 
Extract preparation 
 
The different extracts were prepared by soaking 200g of the powder of N. latifolia leaves in 1 liter of water, 
95% ethanol or hexane in different glass Jars for 2 days at room temperature. The extract was filtered and the 
process repeated three  times. The extracts were concentrated at a lower temperature (<50oC) under reduced pressure 
on a rotary evaporator. The percentage yields of the extracts were 13.4, 16.7 and 3.2% w / w respectively for water, 
ethanol and hexane. 
 
Animals 
 
Wistar strain albino rats (150 – 200g) bred in the Department of Pharmacology and Clinical Pharmacy, 
faculty of Pharmaceutical Sciences A.B.U. Zaria, were used for the study. The animals were fed ad libitum with 
pellet diet (Vital feeds, Jos, Nigeria) and water. They were also kept and maintained under laboratory conditions of 
temperature, humidity and light (24 ± 1 0C, 65% and 12 h light/dark cycle) respectively. We followed the Guide for 
the Care and Use of Laboratory Animals, 1985, issued by the US Department of Health and Human Services, Public 
Health Service, National Institute of Health, NIH Publication No. 86-23. 
 
 
Induction of diabetes 
 
Diabetes was induced in overnight fasted rats by a single intraperitoneal injection of freshly prepared 
streptozotocin (STZ) (45mg / kg body weight) in 0.1M citrate buffer (pH 4.5) in a volume of 1ml / kg (Rakieten et 
al., 1963). Diabetes was confirmed in the STZ - treated rats by measuring the fasting blood glucose concentration 48 
hours after STZ injection. Rats with fasting blood glucose of more than 200mg/dl were considered diabetic and 
included in the study after a stabilization period of 7 days.  
 
Experimental design 
 
To study the glucose–lowering effect of the different extracts, the rats were divided into nine groups of six 
animals each: 
Group 1- Normal – untreated rats, Group 2- Diabetic- untreated rats, Group 3- Normal rats administered 100mg/kg 
bw of plant extract, Group 4- Normal rats administered 200mg/kg bw of plant extract, Group 5- Normal rats 
administered 400mg/kg bw of plant extract, Group 6- Diabetic rats administered 100mg/kg bw of plant extract, 
Group 7- Diabetic rats administered 200mg/kg bw of plant extract, Group 8- Diabetic rats administered 400mg/kg 
bw of plant extract, Group 9- Diabetic rats administered 1mg/kg bw of glibenclamide. 
The rats were fasted for 18 hrs prior to extract administration. The extract suspended in distilled water was 
administered orally by intubation using a feeding tube (BMI, feeding tube, size 8). Groups 1and 2 were fed distilled 
water alone. Blood Samples for glucose estimation were collected in fluoridated eppendorff tubes from the rats’ tail 
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vein at 0,1,2,4 and 6 hours after administering the extract,  water or glibenclamide. Serum glucose concentration was 
determined based on the principle of Trinder (1969), using glucose oxidase kit (Randox, UK).  
 
Statistical Analysis 
 
The results are presented as mean ± standard error of the mean (S.E.M.). Mean blood glucose values at 
0,1,2,4 and 6 hours were compared using one way analysis of variance (one-way ANOVA). Differences between 
two means was analysed by the  student’s t – test. 
 
 
Results  
Effects of the aqueous extract on fasting blood glucose. 
 
The effect of different doses of the aqueous fraction of N. latifolia leaves on fasting blood glucose of 
normoglycaemic and STZ–diabetic rats is shown in Table 1. The three different doses administered to normal rats 
produced slight insignificant decreases in fasting blood glucose. In diabetic rats, the extract significantly (P<0.05) 
lowered their fasting blood glucose with the group administered 400mg / kg body weight showing the maximum 
reduction of 31.7% 4 hrs after treatment. 
 
Effects of the ethanolic extract on fasting blood glucose 
 
The effect of different doses of the ethanolic extract of N. latifolia leaves on fasting blood glucose of 
normoglycaemic and STZ –diabetic rats is shown in Table 2. The ethanolic extract significantly (P<0.05) lowered 
fasting blood glucose of both normal and diabetic rats. The 400mg/kg dose produced the maximal fall of 30.9% in 
normal and 36.1% in diabetic rats. 
 
Effects of the hexane extract on fasting blood glucose.        
 
The effect of different doses of the hexane extract of N. latifolia leaves on fasting blood glucose of 
normoglycaemic and STZ–diabetic rats is shown in Table 3. Statistically (P>0.05) the hexane extract showed no 
lowering effect on blood glucose. A maximum of 4.0% and 2.4% decreases were observed in normal and  diabetic 
rats respectively.   STZ – diabetic rats treated with glibenclamide  showed 35.0% fall in fasting blood glucose which 
is comparable to the diabetic rats administered  400mg/kg extracts of the aqueous and ethanolic extracts. 
 
 
Discussion and conclusion 
 
In this study streptozotocin (STZ) was used for the induction of diabetes mellitus. Streptozotocin is well 
known for its selective pancreatic β-cell cytotoxicity and has been widely used to induce diabetes mellitus in 
experimental rats (Aderibigbe et al., 2001; Ojewole, 2003; Malalavidhane et al., 2003). The persistent 
hyperglycaemia in the STZ-diabetic rats also indicates partial β-cells destruction. Treatment of normal and STZ-
diabetic rats with different doses of the leaves of N. latifolia extracted with water, 95% ethanol and hexane produced 
marked hypoglycaemic effects with the aqueous and ethanolic extracts (Tables 1 and 2). The ethanolic extract 
lowered the fasting blood glucose of both normal and STZ-diabetic rats. The 400mg/kg dose group showed the 
highest decrease in fasting blood glucose of  both normal (30.9%) and diabetic (36.9%) rats.  
The 36.9% reduction of fasting blood glucose of STZ-diabetic rats treated with 400mg/kg dose of ethanolic 
extract was found to be comparable with the 35.5% reduction observed with diabetic group treated with 
glibenclamide. Glibenclamide is often used as a standard drug in STZ-induced moderate diabetic models to compare 
antidiabetic properties of a variety of compounds (Andra-Cetto et al., 2000; Arulselvan and Subramanian, 2007).  
The exact chemical constituent(s) of the plant extract that is / are responsible for the hypoglycaemic effects are not 
known at present.  Preliminary Phytochemical screening of the extracts (data not shown) revealed that the aqueous 
and the ethanolic extracts contain alkaloids, flavonoids, steroids, saponins, glycosides, coumarins and carbohydrates. 
Coumarins, flavonoids, terpenoids and some other secondary plant metabolites have been reported to possess 
hypoglycaemic effect (Marles and Farnsworth, 1995; Ojewole, 2002).  
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Table 1: Effect of different doses of aqueous fraction of the leaves of Nauclea latifolia on fasting blood glucose levels (mg/dl) of normal and diabetic rats (Mean 
± SEM). n=6 
 
 
Treatment 
 
                                                                    Time (Hrs)  
                    0                                 1                                                          2                                4                               6                 
Normal Control 
 
73.59±  2.21 73.16± 2.06 74.29± 2.24 71.90± 2.36 71.47± 1.54 
Diabetic Control 265.51± 6.78 270.51± 8.36 265.13± 7.75 264.74± 7.59 266.28± 6.85 
Normal + 100mg / kg 68.47± 1.74 
 
68.75± 2.28 
 
67.22± 2.89 
(1.8%) 
 
64.72± 2.17 
(5.5%) 
 
64.86± 0.79 
(5.3%) 
 
Normal + 200mg / kg 74.53± 2.14 73.87± 1.92 74.67± 2.58 69.60± 2.01 
(6.6%) 
71.731± 1.44 
(3.8%) 
Normal  + 400 mg / kg 76.88± 1.28 73.44± 2.45 
(4.6%) 
75.49± 1.22 
(1.9%) 
72.84± 2.29 
(5.4%) 
73.57± 1.30 
(4.4%) 
Diabetic + 100 mg / kg 237.60± 2.10 230.67± 3.32 
(2.9%) 
209.20± 4.21** 
(12%) 
183.47± 7.07*** 
(22.8%) 
235.60± 2.98 
(0.8%) 
Diabetic + 200mg / kg 270.93±14.23 248.53± 12.34 
(8.3%) 
213.73±8.29** 
(21.1%) 
188.93± 12.21** 
(30.3%) 
218.93±9.63* 
(19.2%) 
Diabetic + 400mg / kg 303.26± 10.72 
 
266.48± 10.69* 
(12.1%) 
 
234.61± 13.08** 
(22.6%) 
 
207.13± 14.62*** 
(31.7%) 
 
249.62±10.64** 
(17.7%) 
 
Diabetic + Glibenclamide (1mg / 
kg) 
274.03± 13.89 249.11± 12.55 
(9.1%) 
228.87±  12.30* 
(16.5%) 
178.10± 10.28*** 
(35.0%) 
206.35± 11.88** 
(24.7%) 
 
Values in parenthesis are percentage of decreases in blood glucose 
* P <0.05 compared with the initial level of blood glucose (0 h) in the respective group 
** P <0.01 compared with the initial level of blood glucose (0 h) in the respective group 
*** P < 0.001 compared with the initial level of blood glucose (0 h) in the respective grou    
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Table 2: Effect of different doses of ethanolic fraction of the leaves of Nauclea latifolia on fasting blood glucose levels  (mg/dl) of normal and diabetic rats 
(Mean ± SEM). n=6 
 
 
Treatment 
 
                                                                    Time (Hrs)  
                    0                                 1                                                          2                                4                               6                 
Normal Control 
 
73.59±  2.21 73.16± 2.06 74.29± 2.24 71.90± 2.36 71.47± 1.54 
Diabetic Control 265.51± 6.78 270.51± 8.36 265.13± 7.75 264.74± 7.59 266.28± 6.85 
Normal + 100mg / kg 77.04± 1.76 
 
74.93± 1.44 
(2.7%) 
68.56± 1.52** 
(11.0%) 
 
62.44± 0.71*** 
(19.0%) 
 
70.60± 1.56* 
(8.4%) 
 
Normal + 200mg / kg 73.75± 1.78 70.83± 2.16(4.0%) 64.58± 1.34**(12.4%) 55.00± 0.78*** 
(25.4%) 
56.53± 1.64*** 
(23.3%) 
Normal  + 400 mg / kg 77.78± 2.92 70.00± 2.55 
(10.0%) 
59.31± 1.30*** 
(23.7%) 
53.75±1.53*** 
(30.9%) 
62.78± 1.99** 
(19.3%) 
Diabetic + 100 mg / kg 253.33± 4.91 243.07± 4.34 
(4.1%) 
228.53± 2.85** 
(9.8%) 
216.13± 6.91** 
(14.7%) 
223.60± 7.86** 
(11.7%) 
Diabetic + 200mg / kg 276.87±3.99 256.40± 5.75* 
(7.4%) 
233.60±2.56*** 
(15.6%) 
212.13± 0.34*** 
(23.4%) 
186.27±7.57*** 
(32.7%) 
Diabetic + 400mg / kg 360.39± 7.22 
 
335.26± 9.37 
(7.0%) 
 
296.54± 8.39*** 
(17.7%) 
 
251.92± 7.27*** 
(30.1%) 
 
230.39±4.65*** 
(36.9%) 
 
Diabetic + Glibenclamide (1mg / 
kg) 
274.03± 13.89 249.11± 12.55 
(9.1%) 
228.87±  12.30* 
(16.5%) 
178.10± 10.28*** 
(35.0%) 
206.35± 11.88** 
(24.7%) 
 
Values in parenthesis are percentage of decreases in blood glucose 
* P <0.05 compared with the initial level of blood glucose (0 h) in the respective group 
** P <0.01 compared with the initial level of blood glucose (0 h) in the respective group 
*** P < 0.001 compared with the initial level of blood glucose (0 h) in the respective group 
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Table 3: Effect of different doses of hexane fraction of the leaves of Nauclea latifolia on fasting blood glucose levels (mg/dl) of 
               normal and diabetic rats (Mean ± SEM). n=6 
 
 
Treatment 
 
                                                                    Time (Hrs)  
                    0                                 1                                                          2                                4                               6                 
Normal Control 
 
73.59±  2.21 73.16± 2.06 74.29± 2.24 71.90± 2.36 71.47± 1.54 
Diabetic Control 265.51± 6.78  270.51± 8.36 265.13± 7.75 264.74± 7.59 266.28± 6.85 
Normal + 100mg / kg 74.39± 1.65 
 
73.17± 1.48 
 
73.04± 0.95 
 
 
72.49± 1.53 
 
 
72.36± 1.48 
(2.7%) 
 
Normal + 200mg / kg 74.58± 1.96 75.14± 1.85 72.60± 1.36 72.32± 2.42 
 
71.61± 2.00 
(4.0%) 
Normal  + 400 mg / kg 75.52± 2.10 73.81± 1.95 
 
75.49± 2.37 
 
72.97± 2.86 
 
72.83± 2.63 
(3.6%) 
Diabetic + 100 mg / kg 243.14± 7.66 249.44± 5.33 
 
250.00± 5.04 
 
245.52± 6.02 
 
247.06± 7.64 
 
Diabetic + 200mg / kg 272.31±11.86 278.85± 13.41 
 
272.05±12.47 
 
273.46± 10.74 
 
266.80±12.29 
(2.0%) 
Diabetic + 400mg / kg 264.49± 10.97 
 
268.85± 10.83 
 
 
261.79± 12.18 
 
 
258.34± 11.64 
 
 
258.21±11.02 
(2.4%) 
 
Diabetic + Glibenclamide (1mg / 
kg) 
274.03± 13.89 249.11± 12.55 
(9.1%) 
228.87±  12.30* 
(16.5%) 
178.10± 10.28*** 
(35.0%) 
206.35± 11.88** 
(24.7%) 
 
Values in parenthesis are percentage of decreases in blood glucose 
* P <0.05 compared with the initial level of blood glucose (0 h) in the respective group 
** P <0.01 compared with the initial level of blood glucose (0 h) in the respective group 
*** P < 0.001 compared with the initial level of blood glucose (0 h) in the respective group 
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The hypoglycaemic and antihyperglycaemic activity of the extracts of N. latifolia leaves could arise 
through stimulation of insulin secretion from β-cells, increased availability of insulin or  inhibition of intestinal 
absorption of glucose. The exact mechanism of the hypoglycaemic action of the plant extracts remains unknown at 
present but that it produces results similar to that of glibenclamide, supposes at least in part that a certain pancreatic 
activity is possible (Subramoniam et al.,1996; Prince et al., 1999). 
Results of this study support the antidiabetic property of N. latifolia and thus substantiate the traditional use 
of the plant as a remedy for diabetes mellitus. Research is going on to study the effect of long term administration of 
the extracts to diabetic rats and to also probe the nature of the Phytochemical (s) responsible for the hypoglycaemic 
activity. 
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